| Literature DB >> 29434649 |
G Jordakieva1, I Grabovac2, E Valic3, K E Schmidt4, A Graff5, A Schuster5, K Hoffmann-Sommergruber6, C Oberhuber6, O Scheiner6, A Goll7, J Godnic-Cvar1.
Abstract
BACKGROUND: Inhalation exposure to fine and ultrafine particles (UFPs) has been associated with respiratory diseases. However, little is known on the quality, threshold levels and concentration of these particles causing adverse health effects.Entities:
Keywords: Adverse health effects; Airway obstruction; Indoor shooting range; Inflammation; Occupational exposure; Ultrafine particles
Year: 2018 PMID: 29434649 PMCID: PMC5797339 DOI: 10.1186/s12995-018-0187-8
Source DB: PubMed Journal: J Occup Med Toxicol ISSN: 1745-6673 Impact factor: 2.646
Exposure to submicrometer sized airborne particles < 700 nm during 4,5 h of the work shift at 5 different locations
| Location | Duration (in hours) | AM particle concentration (n/cm3) | Median particle size (nm) | Mean particle size (nm) | Dominating Mode (nm) |
|---|---|---|---|---|---|
| A1 | 3.5 | 3.57 × 105 | 54.7 | 67.2 | 56.6 |
| A2 | 3.5 | 5.31 × 105 | 62.3 | 72.8 | 63.3 |
| B1 | 3.5 | 4.66 × 105 | 58.8 | 70.1 | 60.1 |
| B2 | 3.5 | 5.93 × 105 | 60.3 | 70.3 | 64.5 |
| B3 | 4 | 5.39 × 105 | 62.1 | 72.3 | 65.8 |
| C | 3.5 | 4.28 × 105 | 62.8 | 75.4 | 63.4 |
| D | 3.5 | 7.58 × 105 | 78.1 | 89.2 | 83.3 |
| E | 2 | 3.34 × 105 | 98.2 | 109.8 | 101.0 |
A-E: different locations, at location A and B the measurements were repeated on 2 and 3 study days, respectively, in parallel to the medical examinations
AM arithmetic mean
Characteristics of 30 shooting instructors occupationally exposed to UFPs for 4.7 years on average and 30 control participants
| Exposed to UFPs | Controls | ||
|---|---|---|---|
| Age, years (mean) | 34.1 ± 8.0 | 41.9 ± 5.1 | < 0.0001 |
| Current smokers % | 29 | 34 | 0.65b |
| Ex-smokers % | 29 | 31 | 0.87b |
| Years | 6.83 range (0–25) | 13.17 range (0–36) | 0.02a |
| Pack-years | 5.53 range (0–30) | 14.47 range (0–60) | 0.01a |
| Body height in cm | 179.3 ± 5.5 | 181.6 ± 7.3 | 0.18 |
| Body weight in kg | 80.5 ± 11.2 | 84.5 ± 13.2 | 0.08 |
| Systolic BP in mmHg | 128.0 ± 14.1 | 128.0 ± 14.9 | 0.83 |
| Diastolic BP in mmHg | 82.3 ± 10.6 | 82.8 ± 10.1 | 0.71 |
| VC (L) | 5.01 ± 0.93 | 5.45 ± 0.97 | 0.0165 |
| FVC % | 95.6 ± 15.6 | 90.1 ± 13.4 | |
| FEV1% | 96.8 ± 13.2 | 92.8 ± 17.0 | |
| MEF50 (%) | 94.7 ± 25.7 | 90.0 ± 32.0 | |
| MEF25 (%) | 85.7 ± 34.8 | 72.3 ± 36.8 |
Data expressed in mean ± standard deviation
BP blood pressure, VC vital capacity, FEV forced expiratory volume in one second, MEF maximum expiratory flow at 50% of forced VC, MEF maximum expiratory flow at 25% of forced VC
aWilcoxon test
bChiSquare test
Lung function in shooting instructors occupationally exposed to UFPs (3 study points)
| Timepoint 0 | Timepoint 1 | Timepoint 2 | |
|---|---|---|---|
| VC (L) | 5.5 ± 1.0 | 5.3 ± 0.9 | 5.4 ± 0.7 |
| VC (%) | 95.6 ± 15.5 | 93.2 ± 16.2 | 94.6 ± 13.5 |
| FEV1 (L) | 4.6 ± 0.7 | 4.5 ± 0.7 | 4.3 ± 0.6 |
| FEV1 (%) | 96.8 ± 13.2 | 95.0 ± 11.2 | 92.5 ± 10.5 |
| MEF50 (L/s) | 2.8 ± 0.8 | 2.8 ± 0.8 | 2.6 ± 0.7 |
| MEF50 (%) | 94.7 ± 25.7 | 95.8 ± 25. 7 | 89.6 ± 23.0 |
| MEF25 (L/s) | 1.9 ± 0.3 | 2.0 ± 0.2 | 2.0 ± 0.2 |
| MEF25 (%) | 85.7 ± 34.8 | 82.2 ± 32.9 | 77.2 ± 27.2 |
Data expressed in mean ± standard deviation
VC, vital capacity; FEV1, forced expiratory volume in one second; MEF50, maximum expiratory flow at 50% of forced VC; MEF25, maximum expiratory flow at 25% of forced VC
Lung function of control participants (2 study points)
| Timepoint 0 | Timepoint 1 | |
|---|---|---|
| VC (L) | 5.0 ± 0.9 | 5.1 ± 0.8 |
| VC (%) | 90.1 ± 13.4 | 92.6 ± 12.8 |
| FEV1 (L) | 4.2 ± 0.8 | 4.1 ± 0.5 |
| FEV1 (%) | 92.8 ± 17.0 | 91.15 ± 10.1 |
| MEF50 (L/s) | 2.4 ± 0.7 | 2.4 ± 0.7 |
| MEF50 (%) | 90.0 ± 11.9 | 87.1 ± 29.2 |
| MEF25 (L/s) | 1.7 ± 0.3 | 1.7 ± 0.3 |
| MEF25 (%) | 72.3 ± 36.8 | 69.2 ± 26.8 |
Data expressed in mean ± standard deviation
VC vital capacity, FEV forced expiratory volume in one second, MEF maximum expiratory flow at 50% of forced VC, MEF maximum expiratory flow at 25% of forced VC
Biochemical serum parameters in shooting instructors occupationally exposed to UFPs (3 study points)
| Timepoint 0 | Timepoint 1 | Timepoint 2 | ||
|---|---|---|---|---|
| HDL | 51.0 ± 11.6 | 49.2 ± 11.1 | 50.6 ± 11.2 | n.s. |
| LDL | 121.3 ± 39.8 | 111.0 ± 33.9 | 114.0 ± 41.4 | n.s. |
| Cholesterol | 201.3 ± 46.3 | 189.4 ± 44.0 | 196.2 ± 44.3 | n.s. |
| Albumin | 46.8 ± 2.4 | 46.5 ± 3.2 | 45.8 ± 2.7 | 0.0093 |
| IgG | 1066.7 ± 180.5 | 1042.0 ± 183.1 | 1021.4 ± 170.7 | 0.0001 |
| FVII | 101.9 ± 31.0 | 99.0 ± 41.7 | 97.0 ± 33.1 | 0.009 |
| Fibrinogen | 2.5 ± 0.5 | 2.1 ± 0.9 | 2.0 ± 0.7 | 0.003 |
Data expressed in mean ± standard deviation
HDL high-density lipoprotein, LDL low-density lipoprotein, IgG immunoglobulin G, FVII factor VII, n.s. non significant
Biochemical serum parameters of control participants at 2 study points
| Timepoint 0 | Timepoint 1 | ||
|---|---|---|---|
| HDL | 50.2 ± 8.9 | 53.0 ± 9.5 | n.s. |
| LDL | 137.3 ± 35.0 | 139.7 ± 32.5 | n.s. |
| Cholesterol | 220.0 ± 38.3 | 225.5 ± 38.0 | n.s. |
| Albumin | 45.1 ± 1.9 | 44.8 ± 1.8 | n.s. |
| IgG | 1085.1 ± 203.0 | 1099.5 ± 208.4 | n.s. |
| FVII | 110.5 ± 20.2 | 115.0 ± 18.8 | n.s. |
| Fibrinogen | 2.6 ± 0.4 | 2.7 ± 0.4 | n.s. |
Data expressed in mean ± standard deviation
HDL high-density lipoprotein, LDL low-density lipoprotein, IgG immunoglobulin G, FVII factor VII, n.s. non significant
Cytokines in sera from shooting instructors occupationally exposed to UFPs (N = 30)
| Cytokines | Timepoint 0 | Timepoint 1 | Timepoint 2 |
|---|---|---|---|
| IL-2 ng/ml | 4.4 (0–29.9) | 4.0 (0–21.8) | 5.8 (0–51.8) |
| IL-4 ng/ml | 0.2 (0–3.2) | 0.5 (0–2.7) | 0.1 (0–1.0) |
| IL-5 ng/ml | 2.2 (0–28.6) | 2.7 (0–26.5) | 1.4 (0–39.4) |
| IL-6 ng/ml | 0.4 (0–3.1) | 0.9 (0–4.3) | 0.3 (0–1.7) |
| IL-8 ng/ml | 16.0 (0–73.8) | 28.8 (0–244.2) | 25.7 (0–172.6) |
| IFN-γ | 9.6 (0–87.3) | 25.1 (0–153.2) | 10.7 (0–75.1) |
| GM-CSF | 0.6 (0–4.1) | 1.0 (0–6.3) | 0.8 (0–8.4) |
Data expressed in mean (range)
IL interleukin, IFN-γ interferon gamma, GM-CSF granulocyte macrophage colony-stimulating factor
Cytokines in sera of control participants (N = 30)
| Cytokines | Timepoint 0 | Timepoint 1 |
|---|---|---|
| IL-2 ng/ml | 3.0 (0–33.4) | 2.6 (0–34.5) |
| IL-4 ng/ml | 0.02 (0–0.7) | 0.5 (0–13.8) |
| IL-5 ng/ml | 7.5 (0–101.9) | 4.5 (0–43.4) |
| IL-6 ng/ml | 0.3 (0–3.0) | 1.3 (0–26.3) |
| IL-8 ng/ml | 9.6 (0–24.0) | 14.0 (0–87.0) |
| IFN-γ | 11.5 (0–89.1) | 10.6 (0–53.6) |
| GM-CSF | 0.3 (0–1.9) | 0.2 (0–3.4) |
Data expressed in mean (range)
IL interleukin, IFN-γ interferon gamma, GM-CSF granulocyte macrophage colony-stimulating factor